Over-expression of miR-326 inhibited FGF1 expression by targeting its 3′-UTR and further blocked the activity of PI3K/AKT and MEK1/2 pathways, leading to the inhibition of malignant behaviors of glioma cells. The gene discussed is MAP2K1; the disease is central nervous system cancer.